T. Imsuwansri

CoronaVac induces lower neutralising activity against variants of concern than natural infection

S. Sangrajrang, W. Chantratita, A. Thitithanyanont, 2021, The Lancet Infectious Diseases.

SARS-CoV-2 variants of concern exhibit reduced sensitivity to live-virus neutralization in sera from CoronaVac vaccinees and naturally infected COVID-19 patients

W. Chantratita, A. Thitithanyanont, S. Sungkanuparph, 2021, medRxiv.

A randomized, placebo-controlled trial of a nasal spray solution containing broadly potent neutralizing antibodies against SARS-CoV-2 variants in healthy volunteers

P. Opanasopit, P. Saelao, C. Sawangmake, 2022, medRxiv.

Glutamate receptor antagonists for tinnitus

D. Hoare, K. Snidvongs, A. Srisubat, 2016, Cochrane Database of Systematic Reviews.

Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers

Songsak Tongchusak, T. Pisitkun, P. Opanasopit, 2023, Scientific reports.